Cargando…
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track f...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873115/ https://www.ncbi.nlm.nih.gov/pubmed/33568191 http://dx.doi.org/10.1186/s13075-021-02430-0 |
_version_ | 1783649327419228160 |
---|---|
author | Nowell, W. Benjamin Gavigan, Kelly Kannowski, Carol L. Cai, Zhihong Hunter, Theresa Venkatachalam, Shilpa Birt, Julie Workman, Jennifer Curtis, Jeffrey R. |
author_facet | Nowell, W. Benjamin Gavigan, Kelly Kannowski, Carol L. Cai, Zhihong Hunter, Theresa Venkatachalam, Shilpa Birt, Julie Workman, Jennifer Curtis, Jeffrey R. |
author_sort | Nowell, W. Benjamin |
collection | PubMed |
description | BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. METHODS: Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure. RESULTS: Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1–3 within the specified monthly time window (28 days ± 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient’s preferences regarding the importance of these PROs were stable over time. CONCLUSION: The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02430-0. |
format | Online Article Text |
id | pubmed-7873115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78731152021-02-10 Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower Nowell, W. Benjamin Gavigan, Kelly Kannowski, Carol L. Cai, Zhihong Hunter, Theresa Venkatachalam, Shilpa Birt, Julie Workman, Jennifer Curtis, Jeffrey R. Arthritis Res Ther Research Article BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. METHODS: Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure. RESULTS: Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1–3 within the specified monthly time window (28 days ± 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient’s preferences regarding the importance of these PROs were stable over time. CONCLUSION: The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02430-0. BioMed Central 2021-02-10 2021 /pmc/articles/PMC7873115/ /pubmed/33568191 http://dx.doi.org/10.1186/s13075-021-02430-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Nowell, W. Benjamin Gavigan, Kelly Kannowski, Carol L. Cai, Zhihong Hunter, Theresa Venkatachalam, Shilpa Birt, Julie Workman, Jennifer Curtis, Jeffrey R. Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title | Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title_full | Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title_fullStr | Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title_full_unstemmed | Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title_short | Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower |
title_sort | which patient-reported outcomes do rheumatology patients find important to track digitally? a real-world longitudinal study in arthritispower |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873115/ https://www.ncbi.nlm.nih.gov/pubmed/33568191 http://dx.doi.org/10.1186/s13075-021-02430-0 |
work_keys_str_mv | AT nowellwbenjamin whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT gavigankelly whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT kannowskicaroll whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT caizhihong whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT huntertheresa whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT venkatachalamshilpa whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT birtjulie whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT workmanjennifer whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower AT curtisjeffreyr whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower |